Filing Details

Accession Number:
0000899243-21-014861
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-05 17:12:16
Reporting Period:
2021-04-01
Accepted Time:
2021-04-05 17:12:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1088856 Corcept Therapeutics Inc CORT Pharmaceutical Preparations (2834) 770487658
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1817838 Douglas Joseph Lyon C/O Corcept Therapeutics Incorporated
149 Commonwealth Drive
Menlo Park CA 94025
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-04-01 25,000 $11.35 25,000 No 4 M Direct
Common Stock Disposition 2021-04-01 25,000 $23.88 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-04-01 25,000 $0.00 25,000 $11.35
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,000 2029-02-08 No 4 M Direct
Footnotes
  1. These transactions were made pursuant to the terms of a 10b5-1 plan in effect at the time of sale of the shares.
  2. Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $23.79 to $24.13 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.
  3. Shares subject to this stock option vest and become exercisable at the rate of 1/48th of the total number of shares on each monthly anniversary of February 8, 2019, so that the total number of shares subject to this option becomes fully vested and exercisable on February 8, 2023.